Italian nonprofit lands FDA approval for first gene therapy to treat rare genetic disease
Italian nonprofit Fondazione Telethon's Waskyra is an ex vivo gene therapy that can address the root genetic cause of Wiskott-Aldrich syndrome in children and adults.